Ovarian Sarcoma

specific

A rare, aggressive malignant mesenchymal neoplasm that arises from the ovary. The prognosis is poor.

25

Centers

0

Active Trials

—

Cancer Funding

Top Centers for Ovarian Sarcoma(25)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Memorial Sloan Kettering Cancer CenterNew York, NY
NCI Comprehensive
52.0
2
Dana-Farber Cancer InstituteBoston, MA
NCI Comprehensive
52.0
3
Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA
NCI Comprehensive
52.0
4
UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA
NCI Comprehensive
52.0
5
Duke Cancer InstituteDurham, NC
NCI Comprehensive
52.0
6
Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX
NCI Comprehensive
52.0
7
City of Hope Comprehensive Cancer CenterDuarte, CA
NCI Comprehensive
52.0
8
University of Colorado Cancer CenterAurora, CO
NCI Comprehensive
52.0
9
Huntsman Cancer Institute at the University of UtahSalt Lake City, UT
NCI Comprehensive
52.0
10
Case Comprehensive Cancer CenterCleveland, OH
NCI Comprehensive
52.0
11
UC Davis Comprehensive Cancer CenterSacramento, CA
NCI Comprehensive
52.0
12
University of Virginia Cancer CenterCharlottesville, VA
NCI Comprehensive
52.0
13
Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, IN
NCI Comprehensive
52.0
14
The University of Arizona Cancer CenterTucson, AZ
NCI Comprehensive
52.0
15
Cedars-Sinai CancerLos Angeles, CA
52.0
16
Cleveland Clinic Cancer CenterCleveland, OH
52.0
17
Holden Comprehensive Cancer CenterIowa City, IA
NCI Comprehensive
52.0
18
The University of Kansas Cancer CenterKansas City, KS
NCI Comprehensive
52.0
19
Dartmouth Cancer CenterLebanon, NH
NCI Comprehensive
52.0
20
University of Illinois Cancer CenterChicago, IL
52.0
21
UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR
52.0
22
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
52.0
23
Cancer Center at IllinoisUrbana, IL
52.0
24
Princess Margaret Cancer CentreToronto, ON
52.0
25
BC CancerVancouver, BC
52.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →